Medicine Description Menopur 75 IU
Menopur vial is a medication containing a combination of two important fertility hormones: follicle-stimulating hormone (FSH) 75 IU and luteinizing hormone (LH) 75 IU. Menopur is used in women to stimulate the growth and development of eggs in the ovaries to achieve pregnancy in cases of anovulatory infertility caused by functional problems rather than primary ovarian failure. It is also used in men to stimulate sperm production in cases of primary or secondary hypogonadism.
What are the ingredients in Menopur?
Menopur vial contains the following two active ingredients:
Follicle-stimulating hormone (FSH): 75 IU.
Luteinizing hormone (LH): 75 IU.
These hormones are usually extracted from human sources after being purified and prepared for medical use. The vial may also contain inactive ingredients to stabilize and preserve the medication.
Indications for Use of Menopur
Menopur is used in the following cases:
In women: To stimulate the growth of ovarian follicles in women suffering from anovulatory infertility caused by pituitary insufficiency or problems other than primary ovarian failure, with the aim of achieving pregnancy through intrauterine insemination (IUI) or in vitro fertilization (IVF).
In men: To stimulate sperm production in men with primary or secondary hypogonadism, resulting in decreased sperm production. Menopur is usually given in combination with human chorionic gonadotropin (hCG).
Menopur should only be used under the supervision of a medical professional specializing in infertility treatment.
What are the dosages of Menopur?
The dosage and duration of treatment are determined by the infertility specialist based on a careful assessment of the patient's condition and response to treatment. Doses vary greatly between individuals and depend on factors such as the cause of infertility, previous treatment history, and hormonal response.
In women: The dose is usually started low and gradually increased under close monitoring using ultrasound scans and blood hormone levels to assess follicle growth.
In men: Menopur is usually given three times a week in combination with hCG for a period that may extend to several months to stimulate sperm production.
Menopur is given by subcutaneous or intramuscular injection. Patients should learn the correct injection technique or seek help from a healthcare provider.
What are the side effects of Menopur?
Menopur may cause some side effects, including:
In women: Ovarian hyperstimulation syndrome (OHSS), a potentially serious condition characterized by enlarged ovaries and fluid accumulation in the abdomen and chest. Symptoms include pelvic pain, bloating, nausea, vomiting, and rapid weight gain. Local reactions at the injection site, such as redness, pain, and swelling, may also occur.
In men: Side effects may include local reactions at the injection site and breast enlargement (gynecomastia).
Patients should inform their doctor immediately if they experience any concerning side effects.